Remuneration Information • Apr 7, 2022
Remuneration Information
Open in ViewerOpens in native device viewer


DIRECTORS' REPORT in accordance with article 114 bis of Legislative decree no. 58 of 24 February 1998
ON ITEM 2.1 AND 2.2 OF THE AGENDA
REMUNERATION POLICY

Explanatory report of the Board of Directors of doValue S.p.A on points 2.1 and 2.2. on the agenda of the Shareholders' Meeting called, in ordinary session and in single call, on April 28, 2022: Remuneration policy:
Dear Shareholders,
__
We have called the Ordinary Shareholders' Meeting to submit for your approval the proposed "Remuneration Policy for the period 2022-2024" (available on the website www.dovalue.it, in the section "Governance - Shareholders' Meeting of 28 April 2022 ", https://www.dovalue.it/governance/associazione-azionisti), prepared in accordance with the provisions of art. 123-ter of Legislative Decree 58/98 (the TUF) according to which the Shareholders' Meeting is responsible for approving, among other things, the remuneration and incentive policy for general managers, executives with strategic responsibilities and members of the bodies of doValue administration. The approval of the remuneration policy and incentive systems must certify their consistency with longterm strategies, ensuring the correct balance between the fixed and variable components of remuneration and, with regard to the latter, mechanisms aimed at guaranteeing the connection of the remuneration with the long-term objectives.
The Remuneration Policy is strictly connected to the doValue Business Plan, approved by the Company's Board of Directors on 25 January 2022 and presented to the financial community through the Capital Markets Day held on 26 January 2022, and is aligned with the time horizon of the Plan (2022-2024).
Furthermore, in accordance with the obligations under art. 123-ter of Legislative Decree 58/98 (Consolidated Law on Finance), information is provided on the implementation of the Remuneration Policy approved by the Shareholders' Meeting on April 29, 2021 ("Annual report on remuneration paid in 2021). With regard to this specific section, it is proposed to the Shareholders to approve, with a binding resolution, an exception to the 2021 Remuneration Policy regarding the period used as reference for the calculation of the average price of the relevant shares for the purpose of determining the variable component of the remuneration of the '' Chief Executive Officer linked to the achievement of a share price target.
In particular, the component, on which the Board of Directors resolved to propose a derogation to the Shareholders' Meeting, concerns 60% of the annual bonus (MBO) of the Chief Executive Officer. This target was not achieved if we consider only the second half of 2021, while it would have been fully achieved if the entire year 2021 had been evaluated.
The rationale for the decision to take the share price target as a reference during the second half of 2021 alone was guided by the hypothesis that the doValue share (and financial markets in general) at the beginning of 2021 could still be excessively penalized by the given situation. from the Covid-19 pandemic. In reality, this choice resulted in a penalizing result for the CEO following the particular volatility of the stock, principally during the third quarter of 2021.
In addition to the above, it is noted that 2021 showed strong positive results: gross revenues increased to 572.1 million euros, EBITDA, excluding non-recurring items, of 200.9 million euros (EBITDA margin equal to 35%), net profit, excluding non-recurring items, which reached 50.7 million euros, a Financial Leverage of 2.0x as of 31 December 2021, and driving a dividend per share of 0.50 euros. Furthermore, as mentioned, on 25 January 2022 the Board of Directors approved the 2022-2024 Business Plan, illustrating the strategic commitment in line with the long-term interests of doValue's stakeholders.
By virtue of the above circumstances and taking into account that the aforementioned component is an integral part of the long-term remuneration of the Chief Executive Officer, the Nomination and Remuneration Committee, in the meeting of 28 March 2021, proposed not to cancel but rather defer the
______________________________________________________________________________________________________________________________________________

vesting of the aforementioned component, at the end of the mandate of Chief Executive Officer (in conjunction with the evaluation of the MBO for 2023), under the following conditions:
The number of shares assigned will be defined by dividing the target amount expressed in euros by the average price per share of the 12 months preceding the assessment of the vesting conditions, and will be paid subsequently after the Shareholders' Meeting called to approve the 2023 financial statements, without prejudice to the deferral period indicated in the remuneration policy.
The aforementioned waiver proposal, which does not lead to an immediate cash payment, but a total deferral, is aimed to reinforcing an even greater alignment of the CEO's remuneration structure with the Company's growth objectives, also in light of the new strategic economic objectives set in the Business Plan; furthermore, the payment conditions established (including the maintenance of the target value set for 2023, as well as the deferral mechanism) ensure alignment with the interests of the Shareholders and make it possible to appreciate the convenience for the Company.
This derogation will be implemented only in the event of a favorable vote by the Shareholders' Meeting of 28 April 2022.
Dear Shareholders,
______________________________________________________________________________________________________________________________________________
Rome, 28 March 2022
__
For THE BOARD OF DIRECTORS CHAIRMAN Giovanni Castellaneta
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.